Alere Inc. (NYSE:ALR) has released results from a study that shows heart patients benefit from a self-test to monitor B-type natriuretic peptide (BNP) levels. © 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback